ANT Solutions to Implement MES and MBR & EBR Solutions for Pharmaceutical Company ALKALOID AD Skopje

- Advertisement -Translation agency in Poland – professional language servicesTranslation agency in Poland – professional language services

ANT Solutions, a leading provider of production optimisation solutions, has entered into an agreement with ALKALOID, a leading pharmaceutical company in North Macedonia, to implement MES (Manufacturing Execution System) with EBR (Electronic Batch Record) solutions. These innovative systems, collectively known as AlkaMES, aim to enhance the production process, improve efficiency, and ensure compliance in the rapidly evolving pharmaceutical industry./b>

ANT Solutions’ systems are designed to enable pharmaceutical companies to fully leverage advanced machinery, production lines, and employees. By transitioning to paperless operations, the modern pharmaceutical industry saves valuable time for operators and ensures the accuracy of documents. Real-time data collected from specialised production equipment allows managers to analyse the entire process and continuously enhance it.

The implementation will be carried out in multiple phases. The first phase, a pilot project, will focus on solid and packaging processes, including lines and machines such as packaging, blender, tablet press, and coater. Full connectivity and OEE (Overall Equipment Efficiency) monitoring will be established, along with integration with systems like SAP. The first phase will focus on preparing a full Master Batch Record (MBR) and generating EBR with digital signatures. In the second phase, the pilot project will be extended to the remaining lines and machines in solid and packaging processes, with the Shopfloor Warehouse Management System (WMS), including containers management, microstops monitoring and rooms management. The third phase will roll out the pilot project to all lines and machines involved in cephalosporins, semi-solid, and liquids filling and packaging processes. The phased implementation approach ensures a systematic deployment of the MES and MBR&EBR solutions, optimising ALKALOID’s production processes and paving the way for enhanced efficiency and compliance in the pharmaceutical industry. Each phase will be validated by ANT so ALKALOID can work with the system on production. An important aspect of implementation is Generic Master Batch Record. The GMBRs reduce the number of MBRs by grouping processes that always have the same workflow and just differ in their parameter settings. This is especially true in the field of packaging, where there are numerous MBRs due to the numerous product versions, such as the number of pills, the language version of the package inserts, or the container to be used.

The implementation of the MES and MBR&EBR solutions is expected to bring numerous benefits to ALKALOID. Increased process efficiency, resulting from enhanced routing accuracy, is estimated to achieve a 10% improvement. Quality Key Performance Indicators (KPIs) will improve by 8% due to optimised production process control, online parameter monitoring, and tolerance management. The time required for batch control will be reduced by 35% thanks to Electronic Batch Record implementation, which includes data structuring, initial system checks, and automated data collection from lines, machines and IPC devices. Additionally, the system’s Operator’s guide will reduce errors and deviations by 25% by guiding operators through processes and minimising potential errors.

The implementation of ANT Solutions’ MES and MBR&EBR systems will not only optimise ALKALOID’s production processes but also contribute to a fast Return on Investment (ROI). The collaboration between ANT Solutions and ALKALOID represents a commitment to innovation, efficiency, and quality within the pharmaceutical industry.

About ANT Solutions: ANT Solutions is a leading provider of production optimisation solutions, specialising in MES and EBR systems. The company offers comprehensive solutions to businesses, enabling increased efficiency, productivity, and competitiveness in the market.

About ALKALOID AD Skopje: ALKALOID is a renowned pharmaceutical company recognised for its excellence in producing high-quality pharmaceutical products. With a focus on continuous improvement, ALKALOID strives to optimise its production processes and deliver exceptional products to its customers.

More about the project: AlkaMES Project

More about ANT Solutions: https://antsolutions.eu/

Poland’s Cattle Population Falls to Its Lowest Level Since 2016

At the end of 2025, Poland’s cattle population fell...

Poland’s Population Falls to 37.33 Million in 2026

As of 1 January 2026, Poland had a population...

More Than 5 Million Polish Jobs Are Exposed to Generative AI

According to the most comprehensive study to date, by...

Poland Becomes a Trillion-Dollar Economy with Growth Still Ahead

Industrial production in Poland accelerated markedly in June, with...

Fewer Jobs, Higher Pay: Poland’s Labour Market in June 2026

In June 2026, average employment in Poland’s enterprise sector...
Category Sponsorship

Become a Category Sponsor

Position your brand alongside the business stories that matter and build lasting visibility with a relevant audience.

From €11 a day Annual sponsorship
Explore sponsorship
Topics

R&D Salaries in Poland Rise, with Directors Earning Up to PLN 57,000

Although research and development centres continue to recruit far...

China Drives Poland’s Growing Trade Deficit

Poland recorded a PLN 12.5 billion deficit in foreign...

Ailleron Innovation Forum 2026 to Explore Practical AI in Finance

On 4 September 2026, Kraków’s Manggha Museum will host...

NBP Revises Forecasts: GDP Growth at 3.7%, Inflation at 2.9% in 2026

The latest NBP projection puts GDP growth at 3.7%...

Poland’s Workforce by Profession: Top Jobs, Ageing Workforce and AI Risk

Statistics Poland has published the first dataset of this...

Poland Posted Stronger Industrial Results in 2025, with Net Profit at PLN 94.4 Billion

Poland’s industry ended 2025 with stronger production and improved...

Poland’s Leasing Market Grows by Nearly 11% in 2025

Leasing companies in Poland signed 669,000 new contracts worth...

Ten Years After the Brexit Vote, Poland Emerges Among the Few EU Winners

We estimate that Brexit has caused measurable losses in...
Related Articles